Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Perimeter Medical Imaging AI Inc
V.PINK
Alternate Symbol(s):
PYNKF
Healthcare
Medical Devices
Perimeter Medical Imaging AI, Inc. is a medical technology company driven to transform cancer surgery with resolution, real-time, imaging tools to address high unmet medical needs. It develops and commercializes in-procedural medical imaging tools. The Company’s Perimeter Optical Coherence Tomography (OCT) system, which provides cross-sectional, real-time margin visualization of tissue...
microstructures during surgical procedures. The Perimeter S-Series OCT is designed to provide surgeons with the clinical support they need in the OR. The OCT medical imaging system includes an intraoperative device for automated scanning of a tissue specimen that provides a rapid subsurface map of up to a 10 cm by 10 cm surface area; a specimen-handling consumable designed to hold and maintain orientation of the specimen, and an image library and training set. Its machine learning tools and artificial intelligence technology, called ImgAssist AI, through clinical development under its ATLAS AI project.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:PINK)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 03, 2024 4:30pm
New Press Release - Perimeter Provides Update on Canada Postal Strike and Mailing of the Company's 2024 Annual General Meeting Materials
TORONTO and DALLAS, Dec. 3, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, wishes to notify shareholders that in case of disruption due to the ongoing Canada Post strike, the Company's...
read article.
(1)
•••
WhiteknightA
X
View Profile
View Bullboard History
Comment by
WhiteknightA
on Nov 26, 2024 4:33pm
RE:A Position
Nice to have you here, and join. You got in at a very good price point and time. Just be patient that would be my best advice as I've been a holder since 2021. Pink has a lot going for it, and the
...more
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(290)
•••
TheBridge
X
View Profile
View Bullboard History
Post by
TheBridge
on Nov 26, 2024 11:43am
A Position
Pleased to annouce that I have joined the ranks of the PINK group with a position at 55 cents and look forward to being rewarded for the risk that I have taken on along with the others on this
...more
(1)
•••
WhiteknightA
X
View Profile
View Bullboard History
Comment by
WhiteknightA
on Nov 23, 2024 3:16am
RE:RE:Top line results
Well, I agree with you about the results of the top line trial. The volume has been off the chart this past week, so this will take some time to work through the market I think. Once word gets around
...more
(231)
•••
ol_griz
X
View Profile
View Bullboard History
Comment by
ol_griz
on Nov 22, 2024 10:54am
RE:Top line results
After successive NR disappointments with virtually every small cap I own, I sold pre-announcement for .65. Will buy it again if it drops to mid fifties. I feel bad doing it, but it's
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 20, 2024 4:06pm
New Press Release - Perimeter B-Series OCT with ImgAssist AI 2.0 Demonstrates Super-Superiority Compared to Standard-of-Care in Pivotal Clinical Trial
– Intraoperative margin assessment during BCS using Perimeter B-Series OCT with ImgAssist AI 2.0 enabled surgeons to more effectively address residual cancer at the surgical margin as compared to current standard methods –– Primary endpoint met with statistically significant reduction in patients...
read article.
(1)
•••
WhiteknightA
X
View Profile
View Bullboard History
Post by
WhiteknightA
on Nov 20, 2024 1:18pm
Top line results
Big day today, let's see where this takes us. I truly believe these results will exceed expectations and get this FDA approval going. as for price targets, it's much like the weather
...more
(231)
•••
ol_griz
X
View Profile
View Bullboard History
Comment by
ol_griz
on Nov 20, 2024 11:37am
RE:Trial results
Nov. 18 was the date of the target call so I don't know why there is a discrepancy.
(231)
•••
ol_griz
X
View Profile
View Bullboard History
Comment by
ol_griz
on Nov 20, 2024 11:35am
RE:Raymond james $1.50 target
Watch what accusations you are throwing around here, bud. There are different analysts in a firm. I took the target from TD Waterhouse Analyst Centre. Unfortunately, they do not
...more
(1)
•••
WhiteknightA
X
View Profile
View Bullboard History
Post by
WhiteknightA
on Nov 19, 2024 3:22pm
Trial results
I've been watching this company for over 2+ years. It's a very key milestone for the company to finally release the top line results of this trial. Very very exciting time. Yes
...more
(441)
•••
TeamEddie
X
View Profile
View Bullboard History
Post by
TeamEddie
on Nov 18, 2024 8:07pm
Raymond james $1.50 target
no clue why the previous poster is lying Raymond James’ Michael Freeman upgraded Perimeter Medical Imaging AI Inc. (PINK-X) to “outperform” from “market perform” and increased his
...more
(231)
•••
ol_griz
X
View Profile
View Bullboard History
Post by
ol_griz
on Nov 18, 2024 10:38am
Clinical trials
Raymond James likes it - $2.00 target. https://stockhouse.com/news/press-releases/2024/11/18/perimeter-medical-imaging-to-announce-topline-results-from-pivotal-clinical
(1)
•••
WhiteknightA
X
View Profile
View Bullboard History
Post by
WhiteknightA
on Dec 27, 2023 8:54pm
2024
Any ideas or input where the price is going this year?. Has pink bottomed?, are we going up?.
(59)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Nov 10, 2023 7:16pm
Avenir mondial IMAGERIE MEDICAL A.I.
Buy buy buy
(1)
•••
WhiteknightA
X
View Profile
View Bullboard History
Post by
WhiteknightA
on Apr 26, 2023 7:40pm
Sales
Very positive and much needed news for pink, this week. Great job to the sales team, and hopefully we'll have much more on the way. The share price of this stock belongs in the area of $4 per
...more
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments